DANIEL ERNESTO
CASTELLANO GAUNA
Profesor asociado de Ciencias de la Salud
University of Sheffield
Sheffield, Reino UnidoPublications in collaboration with researchers from University of Sheffield (4)
2022
-
Predictive biomarkers for survival benefit with ramucirumab in urothelial cancer in the RANGE trial
Nature communications, Vol. 13, Núm. 1, pp. 1878
2020
-
Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): overall survival and updated results of a randomised, double-blind, phase 3 trial
The Lancet Oncology, Vol. 21, Núm. 1, pp. 105-120
-
Survey of the impact of COVID-19 on oncologists' decision making in cancer
JCO Global Oncology, pp. 1248-1257
2016
-
Randomized open-label phase II trial of apitolisib (GDC-0980), a novel inhibitor of the PI3K/mammalian target of rapamycin pathway, versus everolimus in patients with metastatic renal cell carcinoma
Journal of Clinical Oncology, Vol. 34, Núm. 14, pp. 1660-1668